Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Transitional Cell × veliparib × Clear all

Sponsor

Conditions

Breast Neoplasms 7 Triple Negative Breast Neoplasms 4 Ovarian Neoplasms 4 Glioblastoma 4 Small Cell Lung Carcinoma 3 Neoplasm Metastasis 3 Gliosarcoma 3 Fallopian Tube Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Astrocytoma 3 Rectal Neoplasms 2 Pancreatic Neoplasms 2 Lymphoma, T-Cell 2 Lymphoma, Mantle-Cell 2 Glioma 2 Colorectal Neoplasms 2 Brain Neoplasms 2 Waldenstrom Macroglobulinemia 1 Uterine Cervical Neoplasms 1 Thrombocythemia, Essential 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Sezary Syndrome 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Oropharyngeal Neoplasms 1 Oligodendroglioma 1

Interventions

pembrolizumab 26 atezolizumab 14 Gemcitabine 13 Nivolumab 12 Cisplatin 10 Docetaxel 8 Carboplatin 8 avelumab 7 Mitomycin 7 epacadostat 4 Ipilimumab 4 pemigatinib 3 cabozantinib 3 Paclitaxel 3 Bevacizumab 3 vofatamab 2 rucaparib 2 lenvatinib 2 enfortumab vedotin 2 durvalumab 2 cabazitaxel 2 bempegaldesleukin 2 Standard of Care 2 Specimen Handling 2 Rogaratinib 2 Ramucirumab 2 Radiation 2 Platinum 2 Pemetrexed 2 Magnetic Resonance Spectroscopy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡